Acurx Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Acurx Pharmaceuticals Inc share price today is $1.42, up -2.07%. The stock opened at $1.44 against the previous close of $1.45, with an intraday high of $1.44 and low of $1.38.

Acurx Pharmaceuticals Inc Share Price Chart

Acurx Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Acurx Pharmaceuticals Inc Share Price Performance

$1.42 -0.0207(-2.07%) ACXP at 27 Jul 2026 01:50 PM Biotechnology
Lowest Today 1.38
Highest Today 1.44
Today’s Open 1.44
Prev. Close 1.45
52 Week High 8.66
52 Week Low 1.33
Day’s Range: Low 1.38 High 1.44
52-Week Range: Low 1.33 High 8.66
1 day return -
1 Week return -8.49
1 month return -8.49
3 month return -32.03
6 month return -48.9
1 year return +252.64
3 year return -24.32
5 year return -73.53
10 year return -

Acurx Pharmaceuticals Inc Institutional Holdings

Jane Street Group LLC 1.27

Vanguard Capital Management, LLC 0.72

Vanguard Institutional Extnd Mkt Idx Tr 0.72

Geode Capital Management, LLC 0.58

Vanguard Group Inc 0.54

CAMBRIDGE Invest RESEARCH ADVISORS, INC. 0.47

Fidelity Extended Market Index 0.38

Vanguard Fiduciary Trust Co 0.38

Prospect Financial Services Llc 0.32

Morgan Stanley - Brokerage Accounts 0.15

UBS Group AG 0.15

Spartan Extended Market Index Pool F 0.08

Fidelity Series Total Market Index 0.07

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Index Fund - Lending 0.06

NT Ext Equity Mkt Index Fund - NL 0.06

Wells Fargo & Co 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

Westside Investment Management, Inc. 0.04

Nbc Securities Inc 0.03

Western Wealth Management, LLC 0.03

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.03

Spartan Total Market Index Pool G 0.02

Tower Research Capital LLC 0.02

Fidelity Total Market Index 0.02

MCGUIRE CAPITAL ADVISORS INC 0.02

Barclays PLC 0.01

Group One Trading, LLC 0.01

Cornerstone Planning Group LLC 0.00

Fidelity Nasdaq Composite Index 0.00

Advisor Group Holdings, Inc. 0.00

BlackRock Inc 0.00

State St US Extended Mkt Indx NL Cl C 0.00

SSgA U.S. Total Market Index Strategy 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Index Fund - Ld 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Acurx Pharmaceuticals Inc Market Status

Strong Buy: 1

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Acurx Pharmaceuticals Inc Fundamentals

Market Cap 6.23 M

PB Ratio 0.8886

PE Ratio 0.0

Enterprise Value -2.94 M

Total Assets 7.69 M

Volume 73733

Acurx Pharmaceuticals Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-12723689 -12.7M, FY22:-12091552 -12.1M, FY21:-12681194 -12.7M, FY20:-4600038 -4.6M, FY19:-5931253 -5.9M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-1680982 -1.7M, Q3/2025:-1992790 -2.0M, Q2/2025:-2246279 -2.2M, Q1/2025:-2149193 -2.1M, Q3/2024:-2821597000 -2821.6M

About Acurx Pharmaceuticals Inc & investment objective

Company Information Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Organisation Biotechnology

Employees 4

Industry Biotechnology

CEO Mr. David P. Luci CPA, Esq., J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Acurx Pharmaceuticals Inc FAQs

What is the share price of Acurx Pharmaceuticals Inc today?

The current share price of Acurx Pharmaceuticals Inc is $1.42.

Can I buy Acurx Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Acurx Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Acurx Pharmaceuticals Inc shares in India?

You can easily invest in Acurx Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Acurx Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Acurx Pharmaceuticals Inc?

Acurx Pharmaceuticals Inc has a market cap of $6.23 M.

In which sector does Acurx Pharmaceuticals Inc belong?

Acurx Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Acurx Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Acurx Pharmaceuticals Inc?

The PE ratio of Acurx Pharmaceuticals Inc is N/A and the PB ratio is 0.89.